Embla Medical hf (OCSE:EMBLA)

kr 35.3 0.4 (1.15%) Market Cap: 15.07 Bil Enterprise Value: 18.32 Bil PE Ratio: 31.89 PB Ratio: 2.85 GF Score: 71/100

Full Year 2019 Ossur hf Guidance Call Transcript

Jan 14, 2020 / 02:00PM GMT

Release Date Price: kr50 (-11.35%)

Transcript

JÃ³n Sigurdsson;ssur hf.;CEO;President

&

Yes, thank you and good afternoon. Thank you for joining, all, us on this conference call where we will cover the revised guidance for 2019 based on the preliminary figures for the fourth quarter of 2019.

My name is JÃ³n Sigurdsson. And with me here today is Sveinn SÃ¶lvason, our CFO. We will begin with a short overview, after which we will have a question-and-answer session.

We are today revising our financial guiding for the full year of 2019 due to the lower-than-expected prosthetics sales in the fourth quarter. Preliminary results suggest that sales in the fourth quarter of 2019 amounted to $180 million, corresponding to 1% organic growth and 10% local currency growth. Sales for the full year of 2019 therefore amounted to $686 million, corresponding to 5% organic growth and 16% local currency growth.

EBITDA before special items for the fourth quarter of 2019 amounted to $37 million or 21% of sales. EBITDA before special items for the full year 2019 amounted to $150 million or 22

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.